HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Rajeshwari Sridhara Selected Research

Exanthema (Rash)

1/2010Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).
1/2010FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma.
1/2009Sorafenib for the treatment of unresectable hepatocellular carcinoma.
10/2008FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.
9/2005Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
8/2005FDA drug approval summary: erlotinib (Tarceva) tablets.
2/2005Pemetrexed in malignant pleural mesothelioma.
2/2004United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets.
1/2003FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Rajeshwari Sridhara Research Topics

Disease

11Diarrhea
09/2013 - 01/2003
9Neutropenia
11/2015 - 02/2005
9Exanthema (Rash)
01/2010 - 01/2003
8Breast Neoplasms (Breast Cancer)
11/2015 - 07/2003
8Neoplasms (Cancer)
01/2010 - 01/2003
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2010 - 01/2003
6Prostatic Neoplasms (Prostate Cancer)
08/2015 - 07/2003
6Nausea
09/2014 - 01/2003
6Thrombocytopenia (Thrombopenia)
09/2014 - 03/2005
5Multiple Myeloma
09/2013 - 07/2003
5Disease Progression
09/2013 - 05/2006
3Fatigue
09/2014 - 01/2012
3Neoplasm Metastasis (Metastasis)
01/2014 - 07/2003
3Fever (Fevers)
09/2013 - 03/2005
3Hypertension (High Blood Pressure)
01/2012 - 12/2006
3Asthenia
01/2012 - 05/2006
3Vomiting
03/2005 - 01/2003
2Ovarian Neoplasms (Ovarian Cancer)
10/2015 - 10/2006
2Headache (Headaches)
09/2014 - 03/2005
2Constipation
09/2014 - 03/2005
2Anemia
09/2013 - 06/2012
2Renal Cell Carcinoma (Grawitz Tumor)
01/2010 - 12/2006
2Hypophosphatemia
01/2009 - 12/2006
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2008 - 01/2008
2Philadelphia Chromosome
09/2008 - 01/2008
2Peripheral Nervous System Diseases (PNS Diseases)
07/2008 - 05/2006
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2008 - 09/2006
2Arthralgia (Joint Pain)
08/2005 - 03/2005
2Interstitial Lung Diseases (Interstitial Lung Disease)
02/2004 - 01/2003
2Acne Vulgaris
02/2004 - 01/2003
1Melanoma (Melanoma, Malignant)
10/2014
1Pain (Aches)
09/2014
1Urinary Bladder Neoplasms (Bladder Cancer)
02/2014
1Dyspnea (Shortness of Breath)
09/2013
1Thrombocytosis (Thrombocythemia)
06/2012
1Primary Myelofibrosis (Myelosclerosis)
06/2012
1Primitive Neuroectodermal Tumors (PNET)
01/2012
1Heart Failure
01/2012
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2012
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2010
1Mucositis
01/2010
1Hepatocellular Carcinoma (Hepatoma)
01/2009
1Infarction
01/2009
1Ischemia
01/2009
1Leukopenia
09/2008
1Pneumonia (Pneumonitis)
09/2008
1Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2008
1Blast Crisis (Blast Phase)
01/2008
1Hemorrhage
01/2008
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2007

Drug/Important Bio-Agent (IBA)

5TabletsIBA
10/2014 - 02/2004
5Epidermal Growth Factor Receptor (EGF Receptor)IBA
09/2014 - 08/2005
4docetaxel (Taxotere)FDA Link
11/2013 - 01/2003
4bortezomib (Velcade)FDA Link
09/2013 - 05/2006
4erlotinib (CP 358,774)FDA Link
01/2010 - 08/2005
3taxaneIBA
09/2014 - 07/2008
3trastuzumab (Herceptin)FDA Link
09/2014 - 10/2008
3PlatinumIBA
01/2010 - 01/2003
3Lipase (Acid Lipase)FDA Link
01/2009 - 12/2006
3Phosphotransferases (Kinase)IBA
01/2009 - 12/2006
2letrozole (Femara)FDA LinkGeneric
11/2015 - 08/2005
2sorafenib (BAY 43-9006)FDA Link
01/2009 - 12/2006
2capecitabine (Xeloda)FDA Link
10/2008 - 07/2008
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2008 - 05/2006
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2008 - 12/2007
2imatinib (Gleevec)FDA Link
09/2008 - 01/2008
2Cisplatin (Platino)FDA LinkGeneric
10/2006 - 02/2005
2pemetrexed (MTA)FDA Link
06/2005 - 02/2005
2gefitinib (Iressa)FDA Link
02/2004 - 01/2003
1Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2015
1Estrogens (Estrogen)FDA Link
11/2015
1Dacarbazine (DIC)FDA LinkGeneric
10/2014
1beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
09/2014
1HormonesIBA
07/2014
1Biological Markers (Surrogate Marker)IBA
05/2014
1RadiumIBA
01/2014
1Prednisone (Sone)FDA LinkGeneric
12/2013
1abirateroneIBA
12/2013
1carfilzomibIBA
09/2013
1INCB018424IBA
06/2012
1Janus KinasesIBA
06/2012
1Mesylates (Mesylate)IBA
03/2012
12- (3- amino- 2- hydroxypropyl)hexacosahydro- 3- methoxy- 26- methyl- 20,27- bis(methylene)11,15- 18,21- 24,28- triepoxy- 7,9- ethano- 12,15- methano- 9H,15H- furo(3,2- i)furo(2',3'- 5,6)pyrano(4,3- b)(1,4)dioxacyclopentacosin- 5- (4H)- oneIBA
03/2012
1sunitinib (Sutent)FDA Link
01/2012
110-propargyl-10-deazaaminopterinFDA Link
10/2010
1laromustine (VNP40101M)IBA
01/2010
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2010
1temsirolimusFDA Link
01/2010
1lapatinib (GW572016)FDA Link
10/2008
1lenalidomide (CC 5013)FDA Link
10/2008
14- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- (trifluoromethyl)phenyl)- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)benzamide (nilotinib)FDA Link
09/2008
1Bcr-Abl tyrosine kinaseIBA
09/2008
1ixabepilone (BMS 247550)FDA Link
07/2008
1dasatinib (BMS 354825)FDA Link
01/2008
1Tyrosine (L-Tyrosine)FDA Link
01/2008

Therapy/Procedure

14Drug Therapy (Chemotherapy)
10/2015 - 01/2003
4Castration
08/2015 - 11/2013
1Neoadjuvant Therapy
07/2014
1Therapeutics
10/2010